Citation Impact
Citing Papers
Some Neurophysiological Aspects of Serotonin
1954
Changes in a Population of Hospitalized Patients with Affective Disorders, 1945-1965
1966
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
2020 Standout
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
2017 Standout
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
The Rise, Decline, and Fall of LSD
1991
Survey on the pharmacodynamics of the new antipsychotic risperidone
1994
Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
1998 StandoutNobel
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
2006 Standout
Potential Therapeutic Effects of Psilocybin
2017 Standout
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
On the function of neuromelanin
1996
Brain glycogen re‐awakened
2004
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers
2019 Standout
Psychedelics and Psychedelic-Assisted Psychotherapy
2020
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
2016 Standout
Psychedelics
2016 Standout
The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
2014
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
2014
Clinical applications of hallucinogens: A review.
2016
Dose-Response Study of N,N-Dimethyltryptamine in Humans
1994
The Pharmacology of Lysergic Acid Diethylamide: A Review
2008
The Development of Spatial Representations of Large-Scale Environments
1975 Standout
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
2010 Standout
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences
2020 Standout
A review of MRI findings in schizophrenia
2001 Standout
Psilocybin-induced stimulus control in the rat
2007
Metabolism and functions of glutathione in brain
2000 Standout
The neural basis of psychedelic action
2022 Standout
Therapeutic Applications of Classic Hallucinogens
2016
Tripping on nothing: placebo psychedelics and contextual factors
2020 Standout
Hallucinogenic Drugs in Psychiatric Research and Treatment Perspectives and Prospects
1995
Neurodegenerative diseases and oxidative stress
2004 Standout
Oxidative reactions and schizophrenia: A review-discussion
1997
Brain Energy Metabolism: Focus on Astrocyte-Neuron Metabolic Cooperation
2011 Standout
Fungal secondary metabolism — from biochemistry to genomics
2005 Standout
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
2018
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
2011
Disturbances of one-carbon metabolism in neuropsychiatric disorders: A review
1997
Orientational Perception
1961
Assessing alternative drug control regimes
1996 StandoutNobel
Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.
1956
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
2016 Standout
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors
2017 Standout
Forest before trees: The precedence of global features in visual perception
1977 Standout
The laws of emotion.
1988 Standout
Characterizing the psychological state produced by LSD.
1968
Serotonergic hallucinogens as translational models relevant to schizophrenia
2013
The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness
1954
Negative v Positive Schizophrenia
1982 Standout
Biochemical Theories of Schizophrenia
1959 Science
Some observations on psilocybin, a new hallucinogen, in volunteer subjects
1960
Psychochemicals as Weapons
1962
Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology
2016
Mycotoxins
2003 Standout
Sex differences in unipolar depression: Evidence and theory.
1987 Standout
Human hallucinogen research: guidelines for safety
2008
Model Psychoses Induced by LSD-25 in Normals
1956
Sex Differences and the Epidemiology of Depression
1977 Standout
The dangers of LSD. Analysis of seven months' experience in a university hospital's psychiatric service
1966
Homocysteine and Cardiovascular Disease
1998 Standout
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
2016 Standout
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
2008
Coma, hyperthermia and bleeding associated with massive LSD overdose. A report of eight cases.
1974
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Effects of a Hallucinogenic Agent in Totally Blind Subjects
1963
Coma, Hyperthermia, and Bleeding Associated with Massive LSD Overdose a Report of Eight Cases
1975
Long-term follow-up of psilocybin-facilitated smoking cessation
2016 Standout
A microgenetic approach to perception and thought.
1957
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
2015 Standout
The effects of 5‐hydroxytryptamine on gastric secretion in anaesthetized dogs
1958 StandoutNobel
Lysergic Acid Diethylamide (LSD-25): I. Physiological and Perceptual Responses
1955
American Trip
2020 Standout
Learning theory and the symbolic processes.
1960 Standout
The role of serotonin in the pathophysiology and treatment of schizophrenia
1997
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
A mathematical theory of visual hallucination patterns
1979 Standout
Hallucinogens
2004 Standout
Preparing for the Bursting of the Psychedelic Hype Bubble
2022 Standout
Works of Max Rinkel being referenced
Chemical theories of psychosis.
2000
Mental changes experimentally produced by L. S. D. (d-Lysergic acid diethylamide tartrate)
1952
DECAMETHONIUM BROMIDE (C-10) IN ELECTRIC CONVULSIVE THERAPY
1951
EXPERIMENTAL PSYCHIATRY II
1955
Experimental psychiatry. III. A chemical concept of psychosis.
1954
PHARMACODYNAMICS OF LSD AND MESCALINE
1957
Experimental Psychiatry. V — Psilocybine, a New Psychotogenic Drug
1960
The Biochemical Bases of Psychoses or The Serotonin Hypothesis about Mental Diseases
1963
EXPERIMENTAL SCHIZOPHRENIA-LIKE SYMPTOMS
1952
Experimental psychiatry. IV. Hallucinogens: tools in experimental psychiatry.
1955
Insulin Treatment in Psychiatry
1960
PSYCHODYNAMIC AND THERAPEUTIC ASPECTS OF MESCALINE AND LYSERGIC ACID DIETHYLAMIDE ROUND TABLE
1957